Mr. Ganjawala serves as the Division Director of the Division of Drug Quality 2 (DDQ2), Office of Manufacturing and Product Quality (OMPQ), Office of Compliance (OC), Center for Drug Evaluation and Research (CDER), FDA. Prior to coming to FDA, Mr. Ganjawala spent more than 20 years in quality management positions within world class pharmaceutical and biotech companies.